Concepts of illicit drug quality among darknet market users: Purity, embodied experience, craft and chemical knowledge

International Journal of Drug Policy

Volumn 35, Issue , 2016, Pages 42-49

  Bancroft, Angus ^a   Scott Reid, Peter ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Independent Researcher   (United Kingdom)

Author keywords

Darknet; Drug quality; Knowledge; Potency; Purity

Indexed keywords

ILLICIT DRUG; RECREATIONAL DRUG; STREET DRUG;

ARTICLE; DARKNET MARKET; DATA ANALYSIS; DRUG DEPENDENCE; DRUG POTENCY; DRUG PURITY; DRUG QUALITY; DRUG USE; HUMAN; INTERNET; INTERVIEW; KNOWLEDGE; MARKET; PRIORITY JOURNAL; RECREATION; RELIABILITY; ADULT; COMMERCIAL PHENOMENA; DRUG TRAFFIC; HARM REDUCTION; MALE; MOTIVATION; PSYCHOLOGY; STANDARDS; SUPPLY AND DISTRIBUTION; YOUNG ADULT;

ADULT; COMMERCE; DRUG TRAFFICKING; DRUG USERS; HARM REDUCTION; HUMANS; INTERNET; INTERVIEWS AS TOPIC; MALE; MOTIVATION; STREET DRUGS; YOUNG ADULT;

EID: 84953410492     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2015.11.008     Document Type: Article

References (65)

1. Aldridge, J., Décary-Hétu, D., Not an e-Bay for drugs: The cryptomarket Silk Road as a paradigm shifting criminal innovation (SSRN Scholarly Paper No. ID 2436643). 2014, Social Science Research Network, Rochester, NY Retrieved from http://papers.ssrn.com/abstract=2436643.
2. Association of Internet Researchers, Ethical decision-making and internet research - recommendations from the AoIR Ethics Working Committee (Version 2.0). 2012 Retrieved from http://aoir.org/reports/ethics2.pdf.
3. Barratt, M.J., Discussing illicit drugs in public internet forums: Visibility, stigma, and pseudonymity. Proceedings of the 5th international conference on communities and technologies, Brisbane, 2011, 159–168, 10.1145/2103354.2103376.
4. Barratt, M.J., Ferris, J.A., Winstock, A.R., Use of Silk Road, the online drug marketplace, in the United Kingdom, Australia and the United States. Addiction 109:5 (2014), 774–783, 10.1111/add.12470.
5. Best, D., Beswick, T., Gossop, M., Rees, S., Coomber, R., Witton, J., et al. From the deal to the needle: Drug purchasing and preparation among heroin users in drug treatment in South London. Addiction Research and Theory 12:6 (2004), 539–548.
6. Bourgois, P., Just another night in a shooting gallery. Theory, Culture & Society 15:2 (1998), 37–66, 10.1177/026327698015002002.
7. Buxton, J., Bingham, T., The rise and challenge of dark net drug markets. 2015, Global Drug Policy Observatory, Swansea.
8. Carnwath, T., Smith, I., Heroin century. 2002, Routledge, London.
9. Cole, C., Jones, L., McVeigh, J., Kicman, A., Syed, Q., Bellis, M., Adulterants in illicit drugs: A review of empirical evidence. Drug Testing and Analysis 3:2 (2011), 89–96, 10.1002/dta.220.
10. Coomber, R., Adulteration of Illicit drugs with dangerous substances-the discovery of a myth. Contemporary Drug Problems 24:2 (1997), 239–271.
11. Coomber, R., Vim in the veins – Fantasy or fact: The adulteration of Illicit drugs. Addiction Research & Theory 5:3 (1997), 195–212.
12. Coomber, R., Pusher myths: Re-situating the drug dealer. 2006, Free Association Books, London.
13. Coomber, R., Social fear, drug related beliefs and drug policy. Hunt, G., Milhet, M., Bergeron, H., (eds.) Drugs and culture: Understanding patterns of use and regulation, 2011, Ashgate, Farnham, 15–31.
14. Darke, S., Farrell, M., Would legalizing illicit opioids reduce overdose fatalities? Implications from a natural experiment. Addiction 109:8 (2014), 1237–1242, 10.1111/add.12456.
15. Decorte, T., Quality control by cocaine users: Underdeveloped harm reduction strategies. European Addiction Research 7:4 (2001), 161–175, 10.1159/000050737.
16. Decorte, T., Stories, facts and myths: Perceptions of domestic cultivators on potency and quality of cannabis. Decorte, T., Potter, G.R., Bouchard, M., (eds.) World wide weed: Global trends in cannabis cultivation and its control, 2011, Ashgate, Farnham, 91–108.
17. Decorte, T., Cannabis social clubs in Belgium: Organizational strengths and weaknesses, and threats to the model. International Journal of Drug Policy 26:2 (2015), 122–130, 10.1016/j.drugpo.2014.07.016.
18. Di Forti, M., Marconi, A., Carra, E., Fraietta, S., Trotta, A., Bonomo, M., et al. Proportion of patients in South London with first-episode psychosis attributable to use of high potency cannabis: A case-control study. Lancet Psychiatry 2:3 (2015), 233–238, 10.1016/S2215-0366(14)00117-5.
19. Douglas, M., Risk and blame: Essays in cultural theory. 1992, Routledge, London.
20. Duff, C., Towards a theory of drug use contexts: Space, embodiment and practice. Addiction Research & Theory 15:5 (2007), 503–519.
21. Duff, C., Reassembling (social) contexts: New directions for a sociology of drugs. International Journal of Drug Policy 22:6 (2011), 404–406, 10.1016/j.drugpo.2011.09.005.
22. Duff, C., The social life of drugs. International Journal of Drug Policy 24:3 (2013), 167–172, 10.1016/j.drugpo.2012.12.009.
23. Dwyer, R., Privileging pleasure: Temazepam injection in a heroin marketplace. International Journal of Drug Policy 19:5 (2008), 367–374.
24. Dwyer, R., Moore, D., Beyond neoclassical economics: Social process, agency and the maintenance of order in an Australian illicit drug marketplace. International Journal of Drug Policy 21:5 (2010), 390–398.
25. Dwyer, R., Moore, D., Enacting multiple methamphetamines: The ontological politics of public discourse and consumer accounts of a drug and its effects. International Journal of Drug Policy 24:3 (2013), 203–211, 10.1016/j.drugpo.2013.03.003.
26. Evrard, I., Legleye, S., Cadet-Taïrou, A., Composition, purity and perceived quality of street cocaine in France. International Journal of Drug Policy 21:5 (2010), 399–406, 10.1016/j.drugpo.2010.03.004.
27. Friedman, S.R., de Jong, W., Rossi, D., Touzé, G., Rockwell, R., Des Jarlais, D.C., et al. Harm reduction theory: Users’ culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users’ groups. International Journal of Drug Policy 18:2 (2007), 107–117, 10.1016/j.drugpo.2006.11.006.
28. Gomart, E., Methadone: Six effects in search of a substance. Social Studies of Science 32:1 (2002), 93–135.
29. Harris, M., Forseth, K., Rhodes, T., It's Russian roulette: Adulteration, adverse effects and drug use transitions during the 2010/2011 United Kingdom heroin shortage. International Journal of Drug Policy 26:1 (2015), 51–58, 10.1016/j.drugpo.2014.09.009.
30. Jacinto, C., Duterte, M., Sales, P., Murphy, S., Maximising the highs and minimising the lows: Harm reduction guidance within ecstasy distribution networks. International Journal of Drug Policy 19:5 (2008), 393–400.
31. Jacques, S., Allen, A., Wright, R., Drug dealers’ rational choices on which customers to rip-off. International Journal of Drug Policy 25:2 (2014), 251–256, 10.1016/j.drugpo.2013.11.010.
32. Jauffret-Roustide, M., Self-support for drug users in the context of harm reduction policy: A lay expertise defined by drug users’ life skills and citizenship. Health Sociology Review 18:2 (2009), 159–172, 10.5172/hesr.18.2.159.
33. Katz, J., Seductions of crime: Moral and sensual attractions in doing evil. 1988, Basic Books, New York.
34. Lee, J.P., Battle, R.S., Soller, B., Brandes, N., Thizzin’ – Ecstasy use contexts and emergent social meanings. Addiction Research & Theory 19:6 (2011), 528–541, 10.3109/16066359.2010.545156.
35. Letcher, A., Mad thoughts on mushrooms: Discourse and power in the study of psychedelic consciousness. Anthropology of Consciousness 18:2 (2007), 74–98, 10.1525/ac.2007.18.2.74.
36. Lévi-Strauss, C., The raw and the cooked: Introduction to a science of mythology, 1, 1969, Harper & Row, New York.
37. Mars, S.G., Fessel, J.N., Bourgois, P., Montero, F., Karandinos, G., Ciccarone, D., Heroin-related overdose: The unexplored influences of markets, marketing and source-types in the United States. Social Science & Medicine 140 (2015), 44–53, 10.1016/j.socscimed.2015.06.032.
38. Martin, E., Pharmaceutical virtue. Culture Medicine and Psychiatry 30 (2006), 157–174.
39. Martin, J., Drugs on the dark net: How cryptomarkets are transforming the global trade in illicit drugs. 2014, Palgrave Macmillan, London.
40. Meyers, K., Kaynak, Ö., Bresani, E., Curtis, B., McNamara, A., Brownfield, K., et al. The availability and depiction of synthetic cathinones (i.e., bath salts) on the internet: Do online suppliers employ features to maximize purchases?. International Journal of Drug Policy 26:7 (2015), 670–674, 10.1016/j.drugpo.2015.01.012.
41. Monaghan, M., Drug Policy Governance in the UK: Lessons from changes to and debates concerning the classification of cannabis under the 1971 Misuse of Drugs Act. International Journal of Drug Policy 25:5 (2014), 1025–1030, 10.1016/j.drugpo.2014.02.001.
42. Moore, K., Measham, F., It's the most fun you can have for twenty quid: Motivations, consequences and meanings of British ketamine use. Addiction Research & Theory 16:3 (2008), 231–244.
43. Office of National Drug Control Policy, The price and purity of Illicit drugs: 1981 through the second quarter of 2003. 2004, Executive Office of the President.
44. Parkin, S., Habitus and drug using environments: Health, place and lived-experience. 2013, Ashgate, Farnham.
45. Parkin, S., Coomber, R., Informal sorter houses: A qualitative insight of the shooting gallery phenomenon in a UK setting. Health & Place 15:4 (2009), 981–989, 10.1016/j.healthplace.2009.03.004.
46. Race, K., Party and play: Online hook-up devices and the emergence of PNP practices among gay men. Sexualities 18:3 (2015), 253–275, 10.1177/1363460714550913.
47. Reinarman, C., Cannabis policies and user practices: Market separation, price, potency, and accessibility in Amsterdam and San Francisco. International Journal of Drug Policy 20:1 (2009), 28–37, 10.1016/j.drugpo.2007.11.003.
48. Reuter, P., Caulkins, J.P., Illegal lemons: Price dispersion in cocaine and heroin markets. Bulletin on Narcotics 56:1–2 (2004), 141–165.
49. Rhodes, T., Risk environments and drug harms: A social science for harm reduction approach. International Journal of Drug Policy 20:3 (2009), 193–201, 10.1016/j.drugpo.2008.10.003.
50. Riley, S., Thompson, J., Griffin, C., Turn on, tune in, but don't drop out: The impact of neo-liberalism on magic mushroom users’ (in)ability to imagine collectivist social worlds. International Journal of Drug Policy 21:6 (2010), 445–451, 10.1016/j.drugpo.2010.07.001.
51. Rosino, M., Linders, A., Howard Becker in hyperspace: Social learning in an on-line drug community. Deviant Behavior 36:9 (2015), 725–739, 10.1080/01639625.2014.977114.
52. Sandberg, S., The importance of culture for cannabis markets towards an economic sociology of Illegal drug markets. British Journal of Criminology 52:6 (2012), 1133–1151.
53. Scott, N., Caulkins, J.P., Ritter, A., Quinn, C., Dietze, P., High-frequency drug purity and price series as tools for explaining drug trends and harms in Victoria, Australia. Addiction 110:1 (2015), 120–128, 10.1111/add.12740.
54. Sheridan, J., Butler, R., They're legal so they're safe, right? What did the legal status of BZP-party pills mean to young people in New Zealand?. International Journal of Drug Policy 21:1 (2010), 77–81, 10.1016/j.drugpo.2009.02.002.
55. Shewan, D., Dalgarno, P., Low levels of negative health and social outcomes among non-treatment heroin users in Glasgow (Scotland): Evidence for controlled heroin use?. British Journal of Health Psychology 10 (2005), 1–17.
56. Southgate, E., Hopwood, M., The role of folk pharmacology and lay experts in harm reduction: Sydney gay drug using networks. International Journal of Drug Policy 12:4 (2001), 321–335.
57. Van Hout, M.C., Nod and wave: An internet study of the codeine intoxication phenomenon. International Journal of Drug Policy 26:1 (2015), 67–77, 10.1016/j.drugpo.2014.06.016.
58. Van Hout, M.C., Bingham, T., Silk Road, the virtual drug marketplace: A single case study of user experiences. International Journal of Drug Policy 24:5 (2013), 385–391, 10.1016/j.drugpo.2013.01.005.
59. Van Hout, M.C., Bingham, T., Surfing the Silk Road: A study of users’ experiences. International Journal of Drug Policy 24:6 (2013), 524–529, 10.1016/j.drugpo.2013.08.011.
60. Van Hout, M.C., Bingham, T., Responsible vendors, intelligent consumers: Silk Road, the online revolution in drug trading. International Journal of Drug Policy 25:2 (2014), 183–189, 10.1016/j.drugpo.2013.10.009.
61. Van Hout, M.C., Hearne, E., Word of mouse: Indigenous harm reduction and online consumerism of the synthetic compound methoxphenidine. Journal of Psychoactive Drugs 47:1 (2015), 30–41, 10.1080/02791072.2014.974002.
62. Vitellone, N., The rush: Needle fixation or technical materialization. Journal for Cultural Research 7:2 (2003), 165–177.
63. Vitellone, N., Syringe sociology. British Journal of Sociology 66:2 (2015), 373–390, 10.1111/1468-4446.12124.
64. Vuolo, M., Uggen, C., Lageson, S., Taste clusters of music and drugs: Evidence from three analytic levels. British Journal of Sociology 65:3 (2014), 529–554, 10.1111/1468-4446.12045.
65. Zinberg, N.E., Drug, set and setting: The basis for controlled intoxicant use. 1984, Yale University Press, New Haven, CT.